CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-07 | Lippis Daniel J. CVP, JAPAC | Shares withheld for taxes | −410 | $92.32 | $38K | 23,189.07 |
| 2024-07-07 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Shares withheld for taxes | −82 | $92.32 | $8K | 184,685.81 |
| 2024-06-20 | Lippis Daniel J. CVP, JAPAC | Option exercise 10b5-1 | +535 | $45.28 | $24K | 24,047.74 |
| 2024-06-20 | Lippis Daniel J. CVP, JAPAC | Sale 10b5-1 | −535 | $90.00 | $48K | 23,512.74 |
| 2024-06-20 | Lippis Daniel J. CVP, JAPAC | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −535 | 5,030 | ||
| 2024-06-20 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +5,625 | $45.28 | $255K | 36,186 |
| 2024-06-20 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −400 | $88.11 | $35K | 35,786 |
| 2024-06-20 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −5,225 | $87.47 | $457K | 30,561 |
| 2024-06-20 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,625 | 56,250 | ||
| 2024-06-12 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +5,000 | $45.28 | $226K | 51,935.72 |
| 2024-06-12 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −5,000 | $87.54 | $438K | 46,935.72 |
| 2024-06-12 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 60,500 | ||
| 2024-05-30 | Zovighian Bernard J CEO | Sale 10b5-1 | −8,617 | $87.68 | $756K | 68,217.9 |
| 2024-05-21 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +5,625 | $45.28 | $255K | 36,186 |
| 2024-05-21 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −5,625 | $90.45 | $509K | 30,561 |
| 2024-05-21 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,625 | 61,875 | ||
| 2024-05-11 | SELLERS ROBERT W.A. SVP, Corporate Controller | Shares withheld for taxes | −229 | $86.72 | $20K | 17,081.2 |
| 2024-05-11 | Szyman Catherine M. CVP, Critical Care | Shares withheld for taxes | −827 | $86.72 | $72K | 76,165.44 |
| 2024-05-11 | Wood Larry L Global President TAVR & Surg | Shares withheld for taxes | −985 | $86.72 | $85K | 223,525.74 |
| 2024-05-11 | Lippis Daniel J. CVP, JAPAC | Shares withheld for taxes | −377 | $86.72 | $33K | 23,512.74 |
Page 21 of 27 · 525 trades